Clonegen Biotechnology Private Limited
About Clonegen Biotechnology Private Limited
Data last updated:
Clonegen Biotechnology Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the scientific research segment of the research and development sector. It was incorporated on 16 November 2004.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL2004PTC130558.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Beena Srivastava and Anupam Srivastava.
Its last annual general meeting (AGM) was held on 20 September 2010, and its latest financial statements are for the year ended 31 March 2010. The registered office was at Ja/5B Ashok Vihar, Phase – I, New Delhi, Delhi, India – 110052.
Company details
Contact details
Clonegen Biotechnology Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressJa/5B Ashok Vihar, Phase – I, New Delhi, Delhi, India – 110052
- IndustryResearch & Development, Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Clonegen Biotechnology Private Limited
FY 2010 filings availableFinancial Statement Summary
| Metrics | FY 2009-10 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2009-10 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Clonegen Biotechnology Private Limited, buy the company report.
Board of directors of Clonegen Biotechnology Private Limited
Clonegen Biotechnology has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Beena Srivastava | Director | 17 Nov 2004 | 21 Years 11 Months | As last reported |
| Anupam Srivastava Also directs: Miracle AI Digital Transformation Private Limited | Director | 16 Nov 2004 | 21 Years 11 Months | As last reported |
Legal cases
No court or tribunal cases involving Clonegen Biotechnology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clonegen Biotechnology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Clonegen Biotechnology Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Clonegen Biotechnology Private Limited has 2 board changes on record since 2004: 2 appointments. The latest: Beena Srivastava was appointed as Director on 17 Nov 2004.
Frequently asked questions
Clonegen Biotechnology has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Clonegen Biotechnology was a private limited company based in New Delhi, Delhi, India. The company worked in science research, within the research and development industry. It was incorporated on 16 November 2004 and is registered under CIN U73100DL2004PTC130558. The company has been struck off by the Registrar of Companies and is no longer operational.
Clonegen Biotechnology had 2 directors:
- Beena Srivastava - Director
- Anupam Srivastava - Director
The CIN (Corporate Identification Number) of Clonegen Biotechnology is U73100DL2004PTC130558. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Clonegen Biotechnology is at Ja5B Ashok Vihar, Phase – I, New Delhi, Delhi, India – 110052.
Clonegen Biotechnology was incorporated on 16 November 2004. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Clonegen Biotechnology on record with the MCA are for the year ended 31 March 2010. Its last annual general meeting was held on 20 September 2010. Year-wise statements from 2015 are in the company report.
Clonegen Biotechnology operated in the research and development industry, in the science research segment. It worked in this industry before it was struck off.
Beena Srivastava was appointed as Director on 17 Nov 2004. Anupam Srivastava was appointed as Director on 16 Nov 2004.
Clonegen Biotechnology can be reached at its registered office: Ja5B Ashok Vihar, Phase – I, New Delhi, Delhi, India – 110052.